Eugenio Lucia

Cosenza, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

From static risk to dynamic disease monitoring: the role of MRD and immune profiling in multiple myeloma.

From static risk to dynamic disease monitoring: the role of MRD and immune profiling in multiple myeloma.

Journal: Frontiers in immunology

Published: July 10, 2026

Bispecific Antibodies for Acute Myeloid Leukemia: From Bone Marrow Immune Niche to Clinical Translation.

Bispecific Antibodies for Acute Myeloid Leukemia: From Bone Marrow Immune Niche to Clinical Translation.

Journal: Antibodies (Basel, Switzerland)

Published: June 13, 2026

When MRD Is Not MRD: A Context-Dependent Interpretation in Clinical Decision-Making.

When MRD Is Not MRD: A Context-Dependent Interpretation in Clinical Decision-Making.

Journal: European journal of haematology

Published: June 02, 2026

Ferroptosis in Lymphoproliferative Disorders.

Ferroptosis in Lymphoproliferative Disorders.

Journal: Cells

Published: May 27, 2026

Multiple Myeloma and the Illusion of the Evidence Pyramid.

Multiple Myeloma and the Illusion of the Evidence Pyramid.

Journal: European journal of haematology

Published: May 26, 2026

Rethinking On-Target Off-Tumor Toxicity as a Hematopoietic Continuum.

Rethinking On-Target Off-Tumor Toxicity as a Hematopoietic Continuum.

Journal: European journal of haematology

Published: May 21, 2026

Bridging Randomized Trial Efficacy and Real-World Effectiveness in Multiple Myeloma: Integrating Clinical Trials and Real-World Evidence for Individualized Care.

Bridging Randomized Trial Efficacy and Real-World Effectiveness in Multiple Myeloma: Integrating Clinical Trials and Real-World Evidence for Individualized Care.

Journal: European journal of haematology

Published: May 19, 2026

Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision-Making.

Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision-Making.

Journal: European journal of haematology

Published: May 12, 2026

Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric Assessment.

Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric Assessment.

Journal: European journal of haematology

Published: April 22, 2026

Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic Malignancies.

Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic Malignancies.

Journal: European journal of haematology

Published: April 02, 2026

From Time-Limited Therapy to Treatment-Free Observation: The Evolving Role of MRD in CLL Management.

From Time-Limited Therapy to Treatment-Free Observation: The Evolving Role of MRD in CLL Management.

Journal: European journal of haematology

Published: March 24, 2026

To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted Therapy.

To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted Therapy.

Journal: European journal of haematology

Published: March 22, 2026

Showing 1-12 of 81

Last Updated: 09/26/2026